ClinicalTrials.gov
ClinicalTrials.gov Menu

Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00527683
Recruitment Status : Completed
First Posted : September 11, 2007
Last Update Posted : April 11, 2008
Sponsor:
Collaborator:
Catalyst Pharmaceuticals, Inc.
Information provided by:
New York University School of Medicine